Hadjipavlou Alexander G, Tzermiadianos Michael N, Kakavelakis Kyriakos N, Lander Phillip
Department of Orthopaedics and Traumatology, University of Crete, Heraklion, Crete, Greece.
Eur Spine J. 2009 Mar;18(3):345-51. doi: 10.1007/s00586-008-0791-x. Epub 2008 Nov 25.
Percutaneous radiofrequency ablation is the treatment of choice for osteoid osteoma of the appendicular skeleton. However, difficulties in localizing the lesion in the spine and its proximity to neural elements have yet to make it the prevalent treatment for spine. This study assesses the safety and effectiveness of two percutaneous techniques for ablating osteoid osteoma of the spine. Seven patients were treated between 1998 and 2005. Four patients underwent percutaneous radiofrequency coagulation. The lesions were located at the articular processes of L3 and L4, the lamina of L3 and in the head of the 11th rib. Three patients with lesions in close proximity to neural structures (pedicle of T9, the posterolateral inferior aspect of L3 vertebral body and the inferior articular process of C5) were subjected to percutaneous core excision. Mean follow-up was 4.2 +/- 1.6 years. Three out of four patients who underwent radiofrequency ablation had an immediate and sustained response. One patient with a lesion in the head of the rib failed to respond. The three patients in the group of pecutaneous core excisional biopsy demonstrated immediate relief of pain. However, one patient experienced relapse of symptoms 6 months after transpedicular core excision. CT scan suggested partial targeting of the lesion that corroborated with histologic examination revealing only reactive tissue. Subsequent percutaneous core excision was successful. Therefore, the overall success rate was 85.7%. Mean VAS improved dramatically from 9 +/- 1 to 2 +/- 1 after surgery (P < 0.05). No neurological or other complications were encountered. This study indicates that radiofrequency ablation of spinal osteoid osteomas is safe and reasonably effective when an intact cortical shell separates the nidus from the neural elements. Percutaneous core excision can obviate the risk of thermal damage for lesions located in close proximity to the neural elements. Effectiveness of treatment can also be evaluated by CT scan and histological examination. Difficulties in targeting the nidus can lead to treatment failure. The minimal morbidity and the effectiveness of these minimally invasive procedures make them a valid alternative in the treatment of spinal osteoid osteoma.
经皮射频消融是四肢骨样骨瘤的首选治疗方法。然而,脊柱病变定位困难以及其与神经结构接近,使得它尚未成为脊柱骨样骨瘤的普遍治疗方法。本研究评估了两种经皮技术消融脊柱骨样骨瘤的安全性和有效性。1998年至2005年间对7例患者进行了治疗。4例患者接受了经皮射频凝固治疗。病变位于L3和L4的关节突、L3的椎板以及第11肋头部。3例病变紧邻神经结构(T9椎弓根、L3椎体后外侧下方及C5下关节突)的患者接受了经皮芯样切除。平均随访时间为4.2±1.6年。4例接受射频消融的患者中有3例立即出现持续反应。1例肋骨头部病变患者无反应。经皮芯样切除活检组的3例患者疼痛立即缓解。然而,1例患者在经椎弓根芯样切除术后6个月症状复发。CT扫描提示病变部分靶向,组织学检查证实仅为反应性组织。随后的经皮芯样切除成功。因此,总体成功率为85.7%。术后平均视觉模拟评分(VAS)从9±1显著改善至2±1(P<0.05)。未出现神经或其他并发症。本研究表明,当完整的皮质壳将骨样骨瘤巢与神经结构分隔开时,射频消融脊柱骨样骨瘤是安全且相当有效的。经皮芯样切除可避免紧邻神经结构的病变发生热损伤风险。治疗效果也可通过CT扫描和组织学检查进行评估。靶向骨样骨瘤巢困难可能导致治疗失败。这些微创手术的低发病率和有效性使其成为治疗脊柱骨样骨瘤的有效替代方法。